Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion description "[The depletion of B cells by anti-CD20/19 monoclonal antibody Retuximab� used in autoimmune diseases therapy leads to systemic side effects and should be significantly improved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion evidence source_evidence_literature NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion SIO_000772 21677771 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion wasDerivedFrom befree-2016 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion wasGeneratedBy ECO_0000203 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- befree-2016 importedOn "2016-02-19" NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.